A carregar...

Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling

Use of the subcutaneous (SC) route for administering monoclonal antibodies (mAbs) to treat chronic conditions has been hindered because of an incomplete understanding of fundamental mechanisms controlling mAb absorption from the SC site, and due to the limited translatability of preclinical studies....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharmacokinet Pharmacodyn
Main Authors: Hu, Shihao, D’Argenio, David Z.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529865/
https://ncbi.nlm.nih.gov/pubmed/32500362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-020-09691-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!